U
DXCM icon

UBS’s DexCom DXCM Stock Holding History

UBS’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,000
Closed -$20K – 10437
2014
Q2 		$20K Sell
2,000
-1,600
-44% -$14.2K ﹤0.01% 8074
2014
Q1 		$37K Buy
3,600
+2,000
+125% +$20.7K ﹤0.01% 7240
2013
Q4 		$14K Sell
1,600
-10,400
-87% -$82.3K ﹤0.01% 8577
2013
Q3 		$85K Buy
12,000
+11,600
+2,900% +$73.5K ﹤0.01% 6202
2013
Q2 		$2K Buy
+400
New +$1.92K ﹤0.01% 9772

Other funds holding DXCM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

UBS's DXCM Position: Q3 2014 in Review

UBS reduced its DexCom (DXCM) stake by 22% in Q3 2014, selling an estimated $201K and leaving 71,308 shares worth $713K. The position accounts for ﹤0.01% of the portfolio, ranked #3927.

UBS first reported a position in DXCM in Q2 2013 and has held it in 6 quarters since. The position peaked at $902K in Q2 2014. 200 funds tracked by Wall St. Rank hold DXCM as of Q3 2014.

  • UBS held 71,308 shares of DexCom worth $713K as of Q3 2014.
  • UBS sold 19,644 DexCom shares in Q3 2014, an estimated $201K.
  • DexCom made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3927 holding.
  • UBS first reported a position in DexCom in Q2 2013 and has held it in 6 quarters since.
  • UBS's DexCom position peaked at $902K in Q2 2014.
  • 200 funds tracked by Wall St. Rank held DexCom as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.